Viewing Study NCT04284761


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-27 @ 12:55 AM
Study NCT ID: NCT04284761
Status: COMPLETED
Last Update Posted: 2024-06-24
First Post: 2020-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer
Sponsor: Alessa Therapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Adenocarcinoma View
None Lower Urinary Tract Symptoms View
Keywords: